selected publications
- Low-dose ropeginterferon alfa-2b and peginterferon alfa-2a have comparable efficacy and tolerability in polycythemia vera. Leukemia research. 2025 Letter GET IT
- A pharmacovigilance study of adverse events associated with polycythemia vera treatments using the FDA Adverse Event Reporting System (FAERS) database. Annals of hematology. 2025 Academic Article GET IT
-
DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.
Blood.
2025
Letter
GET IT
Times cited: 1 - A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial. Frontiers in medicine. 2025 Academic Article GET IT
- Automated Information Extraction from Unstructured Hematopathology Reports to Support Response Assessment in Myeloproliferative Neoplasms. Methods of information in medicine. 2025 Academic Article GET IT
-
High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera.
Blood advances.
2025
Academic Article
GET IT
Times cited: 3 - ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera. Acta haematologica. 2025 Academic Article GET IT
- A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms. Pediatric blood & cancer. 2025 Academic Article GET IT
- Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis. Blood neoplasia. 2025 Academic Article GET IT
- PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera. Annals of hematology. 2025 Academic Article GET IT
-
JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms.
Leukemia.
2024
Academic Article
GET IT
Times cited: 5 -
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis.
Annals of hematology.
2024
Academic Article
GET IT
Times cited: 8 -
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry.
Haematologica.
2024
Letter
GET IT
Times cited: 6 -
Are thrombosis, progression, and survival in ET predictable?.
Blood cancer journal.
2024
Letter
GET IT
Times cited: 3 - Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. 2024 GET IT
-
Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes.
Blood advances.
2024
Review
GET IT
Times cited: 8 -
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine.
2024
Academic Article
GET IT
Times cited: 18 -
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection.
2024
Letter
GET IT
Times cited: 6 -
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
2023
Academic Article
GET IT
Times cited: 13 -
Polycythemia vera: aspects of its current diagnosis and initial treatment.
Expert review of hematology.
2023
Academic Article
GET IT
Times cited: 1 -
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Therapeutic advances in hematology.
2023
Academic Article
GET IT
Times cited: 7 -
Splenomegaly (SPML) in polycythemia vera (PV): its clinical significance and its relation to symptoms, post-polycythemic myelofibrosis (PPMF) and survival.
Leukemia.
2022
Academic Article
GET IT
Times cited: 3 -
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).
Frontiers in oncology.
2022
Academic Article
GET IT
Times cited: 15 -
Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome.
Blood advances.
2022
Academic Article
GET IT
Times cited: 9 -
Excess mortality in younger patients with myeloproliferative neoplasms.
Leukemia & lymphoma.
2022
Letter
GET IT
Times cited: 14 -
Normal life expectancy for polycythemia vera (PV) patients is possible.
Leukemia.
2021
Academic Article
GET IT
Times cited: 33 -
Outcomes in CLL patients with NOTCH1 regulatory pathway mutations.
American journal of hematology.
2021
Letter
GET IT
Times cited: 3 -
Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival.
Leukemia.
2021
Academic Article
GET IT
Times cited: 92 -
Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.
Journal of blood medicine.
2020
Review
GET IT
Times cited: 35 -
Megakaryocyte TGFβ1 partitions erythropoiesis into immature progenitor/stem cells and maturing precursors.
Blood.
2020
Academic Article
GET IT
Times cited: 13 -
Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience.
Journal of thrombosis and thrombolysis.
2019
Academic Article
GET IT
Times cited: 11 -
Somatic mutations and cell identity linked by Genotyping of Transcriptomes.
Nature.
2019
Academic Article
GET IT
Times cited: 228 -
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN.
2018
Academic Article
GET IT
Times cited: 16 -
Delayed diagnosis of congenital sideroblastic anemia.
Seminars in hematology.
2017
Editorial Article
GET IT
Times cited: 1 -
Acute myeloid leukemia masquerading as hepatocellular carcinoma.
2016
GET IT
Times cited: 5 -
Diaphragmatic Amyloidosis Causing Respiratory Failure: A Case Report and Review of Literature.
Case reports in oncological medicine.
2015
Academic Article
GET IT
Times cited: 9 -
Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma.
Clinical lymphoma, myeloma & leukemia.
2015
Academic Article
GET IT
Times cited: 19 - From the liver to the foot: a case of systemic embolism and acrometastasis in hepatocellular carcinoma. Gastrointestinal cancer research : GCR. 2014 Academic Article GET IT
-
Hyponatraemia in cancer: association with type of cancer and mortality.
European journal of cancer care.
2014
Academic Article
GET IT
Times cited: 27 -
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
2013
GET IT
Times cited: 12 -
Palliative care knowledge and attitudes among oncology nurses in Qatar.
The American journal of hospice & palliative care.
2013
Academic Article
GET IT
Times cited: 11 -
Attitudes of medical oncologists in Qatar toward palliative care.
The American journal of hospice & palliative care.
2012
Academic Article
GET IT
Times cited: 7 -
Middle East experience in palliative care.
The American journal of hospice & palliative care.
2012
Academic Article
GET IT
Times cited: 18 -
Pattern of hospitalization of patients with cancer in an acute palliative care setting: Qatar's experience.
The American journal of hospice & palliative care.
2012
Academic Article
GET IT
Times cited: 3